NSE · AMBANIORGO · Chemicals
Ambani Orgochem Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹194 Cr with net profit ₹-2 Cr — a -0.79% net margin, versus 2.23% the period before.
Shareholding
As of 2026-06-30
- Promoter54.3%
- Public45.7%
284 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.52× from low to high.
Risk flags
Derived from disclosed data
- Promoter holding fell 6.95 percentage points to 54.3% in the latest disclosure.
Peer comparison
Chemicals · ranked #1 of 159 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Pidilite Industries Ltd. | ₹1,65,887 Cr | 286.45 | 15.31 | 22.61% | 16.77% |
| Solar Industries India Ltd. | ₹1,63,606 Cr | 298.74 | 26.07 | 26.72% | 17.05% |
| SRF Ltd. | ₹78,369 Cr | 134.68 | 5.58 | 13.07% | 11.9% |
| Linde India Limited | ₹57,332 Cr | 740.36 | 13.44 | 12.48% | 0.18% |
| Gujarat Fluorochemicals Ltd. | ₹50,334 Cr | 461.91 | 6.45 | 7.3% | 11.49% |
| Godrej Industries Ltd. | ₹43,559 Cr | 98.05 | 3.9 | 11.1% | 5.58% |
| Navin Fluorine International Ltd. | ₹38,957 Cr | 183.04 | 9.79 | 16.69% | 20.02% |
| Himadri Speciality Chem Limited | ₹38,845 Cr | 193.44 | 8.25 | 15.96% | 16.12% |
| Deepak Nitrite Ltd. | ₹22,840 Cr | 103.95 | 3.91 | 9.43% | 6.98% |
| Deepak Fertilisers & Petrochemicals Corp Ltd. | ₹20,530 Cr | 147.31 | 3 | 10.77% | 6.41% |
| Ambani Orgochem Limited(this company) | — | 60.17 | 1.68 | 2.43% | 0% |
AI analysis
AI-generated · google/gemini-2.5-flashAmbani Orgochem Limited (AMBANIORGO) is listed in the Chemicals sector. As of March 2025, the company reported revenue of Rs 193.93 Cr and a net loss of Rs 1.54 Cr, resulting in an EPS of -2.11. The debt-to-equity ratio was 1.00. The promoter holding stood at 54.30% as of June 2026.
Positives
- +Revenue grew to Rs 193.93 Cr in March 2025 from Rs 87.36 Cr in March 2021.
- +The company's promoter holding of 54.30% is above 50%, indicating significant insider confidence.
Negatives
- −The company reported a net loss of Rs 1.54 Cr in March 2025.
- −The EPS declined to -2.11 in March 2025 from 3.48 in March 2024.
- −The profit margin is 0%, indicating no net profit margin.
- −The debt-to-equity ratio of 1.00 suggests the company is equally financed by debt and equity.
Financial performance
Ambani Orgochem Limited's revenue has shown growth over recent years, reaching Rs 193.93 Cr in March 2025 from Rs 87.36 Cr in March 2021. However, the company reported a net loss of Rs 1.54 Cr in March 2025, a decrease from a net profit of Rs 3.04 Cr in March 2024. Earnings per share (EPS) moved from 1.07 in March 2023 to 3.48 in March 2024, and then to -2.11 in March 2025.
Profitability & returns
The company's return on equity (ROE) was 243.17% and return on capital employed (ROCE) was 6.59%. The profit margin for the latest reported period was 0%. The EPS for March 2025 was -2.11, compared to 3.48 in March 2024. EBITDA was Rs 7.72 Cr in March 2025.
Balance sheet
The company's debt-to-equity ratio is 1.00. The book value per share is Rs 63.33. No information regarding quarterly results was provided to evaluate recent balance sheet changes.
Ownership & pledges
As of June 2026, promoters held 54.30% of the shares. Public shareholding was 45.70%. The number of shareholders increased to 284 in June 2026 from 227 in November 2021. There was no promoter pledging reported.
Data as of — price: 2026-07-30 · financials: Mar 25 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.